search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
TM


Circovac + Hyogen


READY TO MIX


READY TO MIX


One single shot


Circovac + Hyogen


Against M.hyo and PCV2


Making a difference together


Circovac® : emulsion and suspension for emulsion for injection for pigs. Each ml of reconstituted vaccine contains: Inactivated porcine circovirus type 2


(PCV2)³ 1.8 log10 ELISA Units. Excipient: Thiomersal:0.10 mg. Adjuvant: Light paraffi n oil 247 to 250.5 mg. Indications: Piglets: Active immunisation of piglets to reduce faecal excretion of PCV2 and virus load in blood, and as an aid to reduce PCV2-linked clinical signs, including wasting, weight loss and mortality as well as to reduce virus load and lesions in lymphoid tissues associated with PCV2 infection. Safety and effi cacy data are available which demonstrate that this vaccine can be mixed with Hyogen and administered to piglets at one injection site. When mixed with Hyogen, vaccinate only piglets from 3 weeks of age. Onset of immunity: 3 weeks after vaccination when mixed with Hyogen. Duration of immunity: 23 weeks when mixed with Hyogen.


Hyogen® : emulsion for injection for pigs. Per dose. Active substance: Inactivated Mycoplasma hyopneumoniae 2940 strain: min. 5.5


EU. Adjuvants: Light liquid paraffi n187 μl. Escherichia coli J5 LPS is max 38000 Endotoxin unit. Excipient: Thiomersal 50 µg. Indica- tions: For the active immunization of fattening pigs from 3 weeks of age to reduce the occurrence and severity of lung lesions caused by Mycoplasma hyopneumoniae infection.Store and transport refrigerated (2 °C - 8 °C). Do not freeze. Withdrawal period: Zero days.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44